메뉴 건너뛰기




Volumn 115, Issue 2, 2013, Pages 148-151

Effect of single-dose extended-release oral azithromycin on anticoagulation status in warfarinized patients

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTIINFECTIVE AGENT; AZITHROMYCIN; WARFARIN;

EID: 84872324098     PISSN: 22124403     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oooo.2012.08.449     Document Type: Article
Times cited : (6)

References (13)
  • 1
    • 0042469541 scopus 로고    scopus 로고
    • Antibacterial prescribing and warfarin: A review
    • P.J. Rice, R.J. Perry, Z. Afzal, I.H. Stockley Antibacterial prescribing and warfarin: a review Br Dent J 194 2003 411 415
    • (2003) Br Dent J , vol.194 , pp. 411-415
    • Rice, P.J.1    Perry, R.J.2    Afzal, Z.3    Stockley, I.H.4
  • 3
    • 78349265411 scopus 로고    scopus 로고
    • Effect of oseltamivir treatment on anticoagulation: A cross-over study in warfarinized patients
    • B.E. Davies, P.A. Baldó, S.L. Lennon-Chrimes, M. Brewster Effect of oseltamivir treatment on anticoagulation: a cross-over study in warfarinized patients Br J Clin Pharmacol 70 2010 834 843
    • (2010) Br J Clin Pharmacol , vol.70 , pp. 834-843
    • Davies, B.E.1    Baldó, P.A.2    Lennon-Chrimes, S.L.3    Brewster, M.4
  • 4
    • 84855265523 scopus 로고    scopus 로고
    • Efficacy and safety of single-dose 2.0 g azithromycin in the treatment of acute exacerbation of chronic obstructive pulmonary disease
    • N. Asai, Y. Ohkuni, T. Iwasaki, R. Matsunuma, K. Nakashima, Y. Otsuka, N. Kaneko Efficacy and safety of single-dose 2.0 g azithromycin in the treatment of acute exacerbation of chronic obstructive pulmonary disease J Infect Chemother 17 2011 793 798
    • (2011) J Infect Chemother , vol.17 , pp. 793-798
    • Asai, N.1    Ohkuni, Y.2    Iwasaki, T.3    Matsunuma, R.4    Nakashima, K.5    Otsuka, Y.6    Kaneko, N.7
  • 5
    • 70649113651 scopus 로고    scopus 로고
    • Single-dose extended-release oral azithromycin vs. 3-day azithromycin for the treatment of group A β-haemolytic streptococcal pharyngitis/ tonsillitis in adults and adolescents: A double-blind, double-dummy study
    • D.M. Jorgensen Single-dose extended-release oral azithromycin vs. 3-day azithromycin for the treatment of group A β-haemolytic streptococcal pharyngitis/tonsillitis in adults and adolescents: a double-blind, double-dummy study Clin Microbiol Infect 15 2009 1103 1110
    • (2009) Clin Microbiol Infect , vol.15 , pp. 1103-1110
    • Jorgensen, D.M.1
  • 6
    • 80655129370 scopus 로고    scopus 로고
    • Azithromycin concentrations in blood and gingival crevicular fluid after systemic administration
    • P.C. Lai, W. Ho, N. Jain, J.D. Walters Azithromycin concentrations in blood and gingival crevicular fluid after systemic administration J Periodontol 82 2011 1582 1586
    • (2011) J Periodontol , vol.82 , pp. 1582-1586
    • Lai, P.C.1    Ho, W.2    Jain, N.3    Walters, J.D.4
  • 10
    • 0033962690 scopus 로고    scopus 로고
    • Determination of erythromycin, clarithromycin, roxithromycin, and azithromycin in plasma by high-performance liquid chromatography with amperometric detection
    • C. Taninaka, H. Ohtani, E. Hanada, H. Kotaki, H. Sato, T. Iga Determination of erythromycin, clarithromycin, roxithromycin, and azithromycin in plasma by high-performance liquid chromatography with amperometric detection J Chromatogr B Biomed Sci Appl 738 2000 405 411
    • (2000) J Chromatogr B Biomed Sci Appl , vol.738 , pp. 405-411
    • Taninaka, C.1    Ohtani, H.2    Hanada, E.3    Kotaki, H.4    Sato, H.5    Iga, T.6
  • 11
    • 80053179622 scopus 로고    scopus 로고
    • Distribution characteristics of clarithromycin and azithromycin, macrolide antimicrobial agents used for treatment of respiratory infections, in lung epithelial lining fluid and alveolar macrophages
    • K. Togami, S. Chono, K. Morimoto Distribution characteristics of clarithromycin and azithromycin, macrolide antimicrobial agents used for treatment of respiratory infections, in lung epithelial lining fluid and alveolar macrophages Biopharm Drug Dispos 32 2011 389 397
    • (2011) Biopharm Drug Dispos , vol.32 , pp. 389-397
    • Togami, K.1    Chono, S.2    Morimoto, K.3
  • 12
    • 77952309339 scopus 로고    scopus 로고
    • Risk factors of drug interaction between warfarin and nonsteroidal anti-inflammatory drugs in practical setting
    • K.H. Choi, A.J. Kim, I.J. Son, K.H. Kim, K.B. Kim, H. Ahn, E.B. Lee Risk factors of drug interaction between warfarin and nonsteroidal anti-inflammatory drugs in practical setting J Korean Med Sci 25 2010 337 341
    • (2010) J Korean Med Sci , vol.25 , pp. 337-341
    • Choi, K.H.1    Kim, A.J.2    Son, I.J.3    Kim, K.H.4    Kim, K.B.5    Ahn, H.6    Lee, E.B.7
  • 13
    • 0032481644 scopus 로고    scopus 로고
    • Acetaminophen and other risk factors for excessive warfarin anticoagulation
    • E.M. Hylek, H. Heiman, S.J. Skates, M.A. Sheehan, D.E. Singer Acetaminophen and other risk factors for excessive warfarin anticoagulation J Am Med Assoc 279 1998 657 662
    • (1998) J Am Med Assoc , vol.279 , pp. 657-662
    • Hylek, E.M.1    Heiman, H.2    Skates, S.J.3    Sheehan, M.A.4    Singer, D.E.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.